Intraoperative Radiation Therapy Market Outlook:
Advances in technology have expanded the application of
IORT, including early-stage breast cancer, pediatric tumors, retroperitoneal
sarcoma, and recurrent rectal and gynecologic cancers.
Intraoperative radiation therapy is an intensive treatment
in which large doses of ionizing radiation are precisely delivered to the
target site. The task is to visualize the tumor site or tumor bed and separate
the entity from other normal tissues to ensure maximum dose to tumor cells and
minimum dose to normal tissue.
Explore More Insights@ https://www.alliedmarketresearch.com/request-toc-and-sample/11565
Increase In Incidence of Cancer Will Drive The Market
An increase in the incidence and prevalence of cancer is
expected to help the market growth in the near future. According to estimates
by the National Cancer Institute in 2018, about 1,735,350 cases are expected to
be diagnosed and 609, 640 cancer deaths are expected in the United States
alone. The increase in the number of individuals who are concerned about having
a better quality of life is expected to support the growth of the market in the
coming years.
Differentiation between these two tissues helps achieve the
correct therapeutic ratio with intraoperative radiation therapy. The IORT
technique is widely used for colorectal cancer, soft-tissue tumors, recurrent
gynecological cancers, and intra-abdominal tumors.
Increase in clinical trials to expand the applications in
cancer offered by IORT will help the market grow in the coming years. Rising
incidence of cancer will drive the market growth during the forecast period.
Furthermore, technological advances and advantages of intraoperative radiation
therapy compared to other techniques are expected to increase in the near
future.
Key Market Players:
IntraOp Medical Corporation, GMV Innovating Solutions, ZEISS
Group, iCAD Inc, Sensus Healtcare Inc, Variant Medical Systems Inc, Ariane
Medical Systems, Sordina IORT Technologies, Eckert, Ziegler Group,
0 Comments